Showing 1 - 20 results of 173,599 for search '(( 50 mg decrease ) OR ((( 50 we decrease ) OR ( _ ((_ decrease) OR (a decrease)) ))))', query time: 0.87s Refine Results
  1. 1
  2. 2
  3. 3

    Predicting pattern diversity decreases as a function of and . by Selim Haj Ali (21222613)

    Published 2025
    “…<p>For 50 Erdős-Rényi graphs with 30 nodes and 70 edges, we split the results into two columns according to the two initial degenerate unstable eigenmodes  +  : on the left, (if ), and on the right, (if ). …”
  4. 4
  5. 5

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects: “…contraceptives substantially decreased…”
  6. 6

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

    Published 2021
    “…Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). …”
  17. 17
  18. 18

    The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

    Published 2022
    “…<p>For cluster sizes ranging from 1 to 4, we show the fraction of predicted heterozygotes with underlying unexpected intensities and the fraction of heterozygotes that are set to “No Call.” Both quantities decrease with increasing size of heterozygote cluster. …”
  19. 19

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). …”
  20. 20